Observational studyAtencion primaria2026
[Hyperuricaemia as a cardiovascular risk factor].
Observational study in Atencion primaria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze whether elevated uric acid levels are associated with an increased risk of developing cardiovascular events and diseases.
designRetrospective observational cohort study.
settingThe clinical laboratory and inpatient area of the Vic Hospital Consortium (Vic, Barcelona).
participantsUric acid measurements and discharges due to cardiovascular disease recorded in the information systems between 2019 and 2024 were included.
interventionsFrom the automated healthcare information systems, uric acid levels and discharges with a primary diagnosis of cardiovascular disease were extracted. MAIN MEASUREMENTS: Patients were grouped according to normouricemia or hyperuricemia, having one or more hospital discharges during the period, and whether these were strictly cardiovascular or cerebrovascular. Regression models were defined to predict the impact of uricemia on discharges due to cardiovascular disease.
resultsThe analysis included 159,235 uric acid measurements from 60,481 different patients and 3,517 hospital discharges relating to 2,919 patients. For all patients, higher uric acid values were associated with older age. No differences were detected with regard to sex. Hyperuricemia was associated with a higher prevalence of hypertension (82.7 vs. 61.7%) and diabetes mellitus (36.9 vs. 28.0%), but not with dyslipidemia and smoking. In the group without admissions for cardiovascular disease, both age and sex were compared with the two categories of uricemia, and an increase in age and a higher proportion of men were observed in the hyperuricemia group. A logistic regression analysis to predict cardiovascular events showed an odds ratio of 1.080 (95% CI: 1.053-1.108) for uric acid levels, 1.053 (95% CI: 1.050-1.056) for age, and 0.488 (95% CI: 0.443-0.538) for female sex.
conclusionsHyperuricemia is associated with older age and, in patients admitted for cardiovascular disease, also with a higher prevalence of hypertension and diabetes mellitus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.